Annotation Detail for ZFYVE9
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| Signaling by TGF beta |
| Pathway ID | Pathway Name |
|---|
| 200195 | TGF-beta receptor signaling |
| Pathway ID | Pathway Name |
|---|
| P00052 | TGF-beta signaling pathway |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ZFYVE9 mRNA | affects expression | 21346803
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.80 | 16705839 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.12 | 6135515 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.93 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.08 | 21346803 18551238 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.46 | 16705839 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.30 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.84 | 2876786 6135515 2876784 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.95 | 18551238 7678174 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
4.00 | 16049721 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.88 | 18551238 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.45 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
5.41 | 10091137 |
Pharmacogenomics Knowledge Base